News & Events

Recent Firm Activities and Highlights

Boston Millennia Parters
Cecelia Health Completes $13 Million Series B Financing to Transform Lives of People Living with Diabetes and Other Chronic Conditions
Cecelia Health, a leading technology-enabled diabetes and other chronic disease management company, announced today it has completed a $13 million Series B funding round. The investment was co-led by Rittenhouse Ventures and Endo Investors, and includes investments from Boston Millennia Partners, SustainVC, G100 Capital, and others. The funding will enable the company to accelerate and further scale the adoption of the company's technology enabled coaching and telemedicine solutions and expand Cecelia Health’s digital health capabilities. Read Full Release
TrekIT Health Raises $1M in Seed Funding
TrekIT Health, a Philadelphia, PA-based company re-designing the EHR experience for clinicians through predictive data visualization and modern clinical workflow tools, closed $1M in additional seed financing. The round was led by Tech Council Ventures with participation from Boston Millennia Partners Founders Fund and Front Row Fund, who joined existing investors including IP Group, DreamIT Health and Ben Franklin Technology Partners of Southeastern PA. Read Full Release
COTA Supports FDA Assessment of Real-World Data through Membership in COVID-19 Evidence Accelerator
COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is pleased to announce a number of initiatives that are bringing enhanced understanding of COVID-19 in near real-time. Leveraging its past knowledge of real-world evidence applications and learnings, COTA has joined the COVID-19 Evidence Accelerator program, a joint initiative of Friends of Cancer Research (Friends) and the Reagan-Udall Foundation for the Food and Drug Administration. Through this initiative, COTA is delivering findings from its observational, real-world studies using data from over 3,000 patients hospitalized with COVID-19 within the Hackensack Meridian Health network. Read Full Release
BC Platforms and Kaiser Permanente Win 2020 Microsoft Health Innovation Award for Precision Medicine Collaboration
BC Platforms and Kaiser Permanente today announced they are winners of the 2020 Microsoft Health Innovation Award in the Reimagine Health Category for enabling a unique way of pairing clinical and genomic data on the same platform to advance precision medicine capabilities. Read Full Release
2020 MedTech Breakthrough Awards Recognize COTA as the Best Overall Medical Data Solution Provider
Boston, MA – May 18, 2020 – COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is pleased to announce that MedTech Breakthrough has named COTA as a winner in the fourth annual MedTech Breakthrough Awards program for the “Best Overall Medical Data Solution Provider" award. The MedTech Breakthrough Awards recognize the top companies, people, platforms, and products in various industries including health, fitness, and medi Read Full Release
Forefront Telecare Launches Phase 2 of COVID-19 Response for Rural Hospitals
NASHVILLE, Tenn., April 9, 2020 ( - Forefront Telecare, Inc. (Forefront), the leader in providing behavioral telehealth to seniors and other vulnerable adults in rural communities across the United States, announced today the next phase of its #RuralHealthSTRONG COVID-19 Response Program. As part of this program, Forefront is offering behavioral telehealth carts with secure, HIPAA-compliant video conferencing at no-cost to hundreds of rural hospitals nationwide. This proven platform has already been deployed by Forefront to over 200 facilities across the country. Read Full Release
Introducing the BBJ’s Fast 50, The Region’s Fastest Growing Companies
The BosBizJournal has recognized COTA on its 2020 Fast 50 list! We are proud to be one of the fastest-growing private companies in MA this year & are committed to continuing on this path as we transform #cancer care. Congrats to all companies. #BBJFAST50 Read Full Release
Reveleer COVID-19 Business Continuity Update
Dear friends, As the world continues to rapidly change around us due to Coronavirus (COVID-19), we wanted to reach out to our partners, and prospective partners, to let you know what to expect from Reveleer during this challenging time.First and foremost, our thoughts go out to those who have been directly impacted by COVID-19 and those working on the front lines to treat and control the spread of illness.... Read Full Release
MedAptus Again Leads KLAS Mobile Charge Capture Rankings
The annual "Best in KLAS" report is out and for the tenth time since 2011, medaptus has earned a top ranking, this year in the Mobile Charge Capture category. The "2020 Best in KLAS Awards: Software & Services" names the top-performing healthcare IT and services companies based on customer feedback obtained in 2019. This latest award recognizes the performance of medaptus' charge capture technology which enables efficient, accurate, and complete coding and billing. Beyond the software's ability to "capture" a charge, a robust rules engine and interface gateway enable real-time charge management and reconciliation activities, regardless of charge source. This unique automation replaces manual processes with intelligence such as work queues that route charge data based on exception. This approach expedites the billing cycle and with less administrative effort.  Read Full Release
COTA Genomic Profiling Study Released
A retrospective review of the COTA Real World Data (RWD) database was performed to identify patients with pathologically confirmed metastatic colon cancer (mCC) diagnosed between January 1, 2013 and December 1, 2017. Although guidelines recommend molecular testing for patients with mCRC, the current study included patients with mCC and excluded rectal cancer cases. At the time of data extraction, the COTA database included demographic, diagnostic, treatment, and quality-of-care information for patients with colon cancer abstracted from the electronic health records from 23 practices including 258 oncologists in Arkansas, Maryland, Michigan, New Jersey, New York, and Tennessee who contribute data under Business Associate Agreements. All data were de-identified to be compliant with Health Insurance Portability and Accountability Act and Office of Health Promotion Research regulations for purposes of secondary research use. The structure of the COTA database has been reviewed by the Western Institutional Review Board and has been deemed exempt from patient informed consent. Read Full Release